Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
31,654
archived clinical trials in
Cardiology

Evaluate Safety and Efficacy of the OPTIMIZER® System in Subjects With Moderate-to-Severe Heart Failure: FIX-HF-5C
Evaluation of the Safety and Efficacy of the OPTIMIZER® System in Subjects With Moderate-to-Severe Heart Failure With Ejection Fraction Between 25% and 45%: FIX-HF-5C
Status: Enrolling
Updated:  12/31/1969
mi
from
New Haven, CT
Evaluate Safety and Efficacy of the OPTIMIZER® System in Subjects With Moderate-to-Severe Heart Failure: FIX-HF-5C
Evaluation of the Safety and Efficacy of the OPTIMIZER® System in Subjects With Moderate-to-Severe Heart Failure With Ejection Fraction Between 25% and 45%: FIX-HF-5C
Status: Enrolling
Updated: 12/31/1969
Yale-New Haven Hospital
mi
from
New Haven, CT
Click here to add this to my saved trials
Evaluate Safety and Efficacy of the OPTIMIZER® System in Subjects With Moderate-to-Severe Heart Failure: FIX-HF-5C
Evaluation of the Safety and Efficacy of the OPTIMIZER® System in Subjects With Moderate-to-Severe Heart Failure With Ejection Fraction Between 25% and 45%: FIX-HF-5C
Status: Enrolling
Updated:  12/31/1969
mi
from
Orlando, FL
Evaluate Safety and Efficacy of the OPTIMIZER® System in Subjects With Moderate-to-Severe Heart Failure: FIX-HF-5C
Evaluation of the Safety and Efficacy of the OPTIMIZER® System in Subjects With Moderate-to-Severe Heart Failure With Ejection Fraction Between 25% and 45%: FIX-HF-5C
Status: Enrolling
Updated: 12/31/1969
Florida Hospital
mi
from
Orlando, FL
Click here to add this to my saved trials
Evaluate Safety and Efficacy of the OPTIMIZER® System in Subjects With Moderate-to-Severe Heart Failure: FIX-HF-5C
Evaluation of the Safety and Efficacy of the OPTIMIZER® System in Subjects With Moderate-to-Severe Heart Failure With Ejection Fraction Between 25% and 45%: FIX-HF-5C
Status: Enrolling
Updated:  12/31/1969
mi
from
Tampa, FL
Evaluate Safety and Efficacy of the OPTIMIZER® System in Subjects With Moderate-to-Severe Heart Failure: FIX-HF-5C
Evaluation of the Safety and Efficacy of the OPTIMIZER® System in Subjects With Moderate-to-Severe Heart Failure With Ejection Fraction Between 25% and 45%: FIX-HF-5C
Status: Enrolling
Updated: 12/31/1969
Florida Hospital - Pepin Heart Institute
mi
from
Tampa, FL
Click here to add this to my saved trials
Evaluate Safety and Efficacy of the OPTIMIZER® System in Subjects With Moderate-to-Severe Heart Failure: FIX-HF-5C
Evaluation of the Safety and Efficacy of the OPTIMIZER® System in Subjects With Moderate-to-Severe Heart Failure With Ejection Fraction Between 25% and 45%: FIX-HF-5C
Status: Enrolling
Updated:  12/31/1969
mi
from
Naperville, IL
Evaluate Safety and Efficacy of the OPTIMIZER® System in Subjects With Moderate-to-Severe Heart Failure: FIX-HF-5C
Evaluation of the Safety and Efficacy of the OPTIMIZER® System in Subjects With Moderate-to-Severe Heart Failure With Ejection Fraction Between 25% and 45%: FIX-HF-5C
Status: Enrolling
Updated: 12/31/1969
Advocate Medical Group - Midwest Heart Foundation
mi
from
Naperville, IL
Click here to add this to my saved trials
Evaluate Safety and Efficacy of the OPTIMIZER® System in Subjects With Moderate-to-Severe Heart Failure: FIX-HF-5C
Evaluation of the Safety and Efficacy of the OPTIMIZER® System in Subjects With Moderate-to-Severe Heart Failure With Ejection Fraction Between 25% and 45%: FIX-HF-5C
Status: Enrolling
Updated:  12/31/1969
mi
from
Iowa City, IA
Evaluate Safety and Efficacy of the OPTIMIZER® System in Subjects With Moderate-to-Severe Heart Failure: FIX-HF-5C
Evaluation of the Safety and Efficacy of the OPTIMIZER® System in Subjects With Moderate-to-Severe Heart Failure With Ejection Fraction Between 25% and 45%: FIX-HF-5C
Status: Enrolling
Updated: 12/31/1969
University of Iowa Hospitals and Clinics
mi
from
Iowa City, IA
Click here to add this to my saved trials
Evaluate Safety and Efficacy of the OPTIMIZER® System in Subjects With Moderate-to-Severe Heart Failure: FIX-HF-5C
Evaluation of the Safety and Efficacy of the OPTIMIZER® System in Subjects With Moderate-to-Severe Heart Failure With Ejection Fraction Between 25% and 45%: FIX-HF-5C
Status: Enrolling
Updated:  12/31/1969
mi
from
Lexington, KY
Evaluate Safety and Efficacy of the OPTIMIZER® System in Subjects With Moderate-to-Severe Heart Failure: FIX-HF-5C
Evaluation of the Safety and Efficacy of the OPTIMIZER® System in Subjects With Moderate-to-Severe Heart Failure With Ejection Fraction Between 25% and 45%: FIX-HF-5C
Status: Enrolling
Updated: 12/31/1969
Baptist Health Lexington
mi
from
Lexington, KY
Click here to add this to my saved trials
Evaluate Safety and Efficacy of the OPTIMIZER® System in Subjects With Moderate-to-Severe Heart Failure: FIX-HF-5C
Evaluation of the Safety and Efficacy of the OPTIMIZER® System in Subjects With Moderate-to-Severe Heart Failure With Ejection Fraction Between 25% and 45%: FIX-HF-5C
Status: Enrolling
Updated:  12/31/1969
mi
from
New Orleans, LA
Evaluate Safety and Efficacy of the OPTIMIZER® System in Subjects With Moderate-to-Severe Heart Failure: FIX-HF-5C
Evaluation of the Safety and Efficacy of the OPTIMIZER® System in Subjects With Moderate-to-Severe Heart Failure With Ejection Fraction Between 25% and 45%: FIX-HF-5C
Status: Enrolling
Updated: 12/31/1969
Ochsner Clinic
mi
from
New Orleans, LA
Click here to add this to my saved trials
Evaluate Safety and Efficacy of the OPTIMIZER® System in Subjects With Moderate-to-Severe Heart Failure: FIX-HF-5C
Evaluation of the Safety and Efficacy of the OPTIMIZER® System in Subjects With Moderate-to-Severe Heart Failure With Ejection Fraction Between 25% and 45%: FIX-HF-5C
Status: Enrolling
Updated:  12/31/1969
mi
from
Baltimore, MD
Evaluate Safety and Efficacy of the OPTIMIZER® System in Subjects With Moderate-to-Severe Heart Failure: FIX-HF-5C
Evaluation of the Safety and Efficacy of the OPTIMIZER® System in Subjects With Moderate-to-Severe Heart Failure With Ejection Fraction Between 25% and 45%: FIX-HF-5C
Status: Enrolling
Updated: 12/31/1969
University of Maryland
mi
from
Baltimore, MD
Click here to add this to my saved trials
Evaluate Safety and Efficacy of the OPTIMIZER® System in Subjects With Moderate-to-Severe Heart Failure: FIX-HF-5C
Evaluation of the Safety and Efficacy of the OPTIMIZER® System in Subjects With Moderate-to-Severe Heart Failure With Ejection Fraction Between 25% and 45%: FIX-HF-5C
Status: Enrolling
Updated:  12/31/1969
mi
from
Takoma Park, MD
Evaluate Safety and Efficacy of the OPTIMIZER® System in Subjects With Moderate-to-Severe Heart Failure: FIX-HF-5C
Evaluation of the Safety and Efficacy of the OPTIMIZER® System in Subjects With Moderate-to-Severe Heart Failure With Ejection Fraction Between 25% and 45%: FIX-HF-5C
Status: Enrolling
Updated: 12/31/1969
Washington Adventist Hospital
mi
from
Takoma Park, MD
Click here to add this to my saved trials
Evaluate Safety and Efficacy of the OPTIMIZER® System in Subjects With Moderate-to-Severe Heart Failure: FIX-HF-5C
Evaluation of the Safety and Efficacy of the OPTIMIZER® System in Subjects With Moderate-to-Severe Heart Failure With Ejection Fraction Between 25% and 45%: FIX-HF-5C
Status: Enrolling
Updated:  12/31/1969
mi
from
Boston, MA
Evaluate Safety and Efficacy of the OPTIMIZER® System in Subjects With Moderate-to-Severe Heart Failure: FIX-HF-5C
Evaluation of the Safety and Efficacy of the OPTIMIZER® System in Subjects With Moderate-to-Severe Heart Failure With Ejection Fraction Between 25% and 45%: FIX-HF-5C
Status: Enrolling
Updated: 12/31/1969
Beth Israel Deaconess Medical Center
mi
from
Boston, MA
Click here to add this to my saved trials
Evaluate Safety and Efficacy of the OPTIMIZER® System in Subjects With Moderate-to-Severe Heart Failure: FIX-HF-5C
Evaluation of the Safety and Efficacy of the OPTIMIZER® System in Subjects With Moderate-to-Severe Heart Failure With Ejection Fraction Between 25% and 45%: FIX-HF-5C
Status: Enrolling
Updated:  12/31/1969
mi
from
Brighton, MA
Evaluate Safety and Efficacy of the OPTIMIZER® System in Subjects With Moderate-to-Severe Heart Failure: FIX-HF-5C
Evaluation of the Safety and Efficacy of the OPTIMIZER® System in Subjects With Moderate-to-Severe Heart Failure With Ejection Fraction Between 25% and 45%: FIX-HF-5C
Status: Enrolling
Updated: 12/31/1969
St Elizabeth's Medical Center
mi
from
Brighton, MA
Click here to add this to my saved trials
Evaluate Safety and Efficacy of the OPTIMIZER® System in Subjects With Moderate-to-Severe Heart Failure: FIX-HF-5C
Evaluation of the Safety and Efficacy of the OPTIMIZER® System in Subjects With Moderate-to-Severe Heart Failure With Ejection Fraction Between 25% and 45%: FIX-HF-5C
Status: Enrolling
Updated:  12/31/1969
mi
from
Detroit, MI
Evaluate Safety and Efficacy of the OPTIMIZER® System in Subjects With Moderate-to-Severe Heart Failure: FIX-HF-5C
Evaluation of the Safety and Efficacy of the OPTIMIZER® System in Subjects With Moderate-to-Severe Heart Failure With Ejection Fraction Between 25% and 45%: FIX-HF-5C
Status: Enrolling
Updated: 12/31/1969
Detroit Medical Center Cardiovascular Institute
mi
from
Detroit, MI
Click here to add this to my saved trials
Evaluate Safety and Efficacy of the OPTIMIZER® System in Subjects With Moderate-to-Severe Heart Failure: FIX-HF-5C
Evaluation of the Safety and Efficacy of the OPTIMIZER® System in Subjects With Moderate-to-Severe Heart Failure With Ejection Fraction Between 25% and 45%: FIX-HF-5C
Status: Enrolling
Updated:  12/31/1969
mi
from
Lincoln, NE
Evaluate Safety and Efficacy of the OPTIMIZER® System in Subjects With Moderate-to-Severe Heart Failure: FIX-HF-5C
Evaluation of the Safety and Efficacy of the OPTIMIZER® System in Subjects With Moderate-to-Severe Heart Failure With Ejection Fraction Between 25% and 45%: FIX-HF-5C
Status: Enrolling
Updated: 12/31/1969
Nebraska Heart Institute
mi
from
Lincoln, NE
Click here to add this to my saved trials
Evaluate Safety and Efficacy of the OPTIMIZER® System in Subjects With Moderate-to-Severe Heart Failure: FIX-HF-5C
Evaluation of the Safety and Efficacy of the OPTIMIZER® System in Subjects With Moderate-to-Severe Heart Failure With Ejection Fraction Between 25% and 45%: FIX-HF-5C
Status: Enrolling
Updated:  12/31/1969
mi
from
Newark, NJ
Evaluate Safety and Efficacy of the OPTIMIZER® System in Subjects With Moderate-to-Severe Heart Failure: FIX-HF-5C
Evaluation of the Safety and Efficacy of the OPTIMIZER® System in Subjects With Moderate-to-Severe Heart Failure With Ejection Fraction Between 25% and 45%: FIX-HF-5C
Status: Enrolling
Updated: 12/31/1969
UMDNJ
mi
from
Newark, NJ
Click here to add this to my saved trials
Evaluate Safety and Efficacy of the OPTIMIZER® System in Subjects With Moderate-to-Severe Heart Failure: FIX-HF-5C
Evaluation of the Safety and Efficacy of the OPTIMIZER® System in Subjects With Moderate-to-Severe Heart Failure With Ejection Fraction Between 25% and 45%: FIX-HF-5C
Status: Enrolling
Updated:  12/31/1969
mi
from
New York, NY
Evaluate Safety and Efficacy of the OPTIMIZER® System in Subjects With Moderate-to-Severe Heart Failure: FIX-HF-5C
Evaluation of the Safety and Efficacy of the OPTIMIZER® System in Subjects With Moderate-to-Severe Heart Failure With Ejection Fraction Between 25% and 45%: FIX-HF-5C
Status: Enrolling
Updated: 12/31/1969
Mt. Sinai Medical Center
mi
from
New York, NY
Click here to add this to my saved trials
Evaluate Safety and Efficacy of the OPTIMIZER® System in Subjects With Moderate-to-Severe Heart Failure: FIX-HF-5C
Evaluation of the Safety and Efficacy of the OPTIMIZER® System in Subjects With Moderate-to-Severe Heart Failure With Ejection Fraction Between 25% and 45%: FIX-HF-5C
Status: Enrolling
Updated:  12/31/1969
mi
from
Cincinnati, OH
Evaluate Safety and Efficacy of the OPTIMIZER® System in Subjects With Moderate-to-Severe Heart Failure: FIX-HF-5C
Evaluation of the Safety and Efficacy of the OPTIMIZER® System in Subjects With Moderate-to-Severe Heart Failure With Ejection Fraction Between 25% and 45%: FIX-HF-5C
Status: Enrolling
Updated: 12/31/1969
The Lindner Center
mi
from
Cincinnati, OH
Click here to add this to my saved trials
Evaluate Safety and Efficacy of the OPTIMIZER® System in Subjects With Moderate-to-Severe Heart Failure: FIX-HF-5C
Evaluation of the Safety and Efficacy of the OPTIMIZER® System in Subjects With Moderate-to-Severe Heart Failure With Ejection Fraction Between 25% and 45%: FIX-HF-5C
Status: Enrolling
Updated:  12/31/1969
mi
from
Columbus, OH
Evaluate Safety and Efficacy of the OPTIMIZER® System in Subjects With Moderate-to-Severe Heart Failure: FIX-HF-5C
Evaluation of the Safety and Efficacy of the OPTIMIZER® System in Subjects With Moderate-to-Severe Heart Failure With Ejection Fraction Between 25% and 45%: FIX-HF-5C
Status: Enrolling
Updated: 12/31/1969
Ohio State University Medical Center
mi
from
Columbus, OH
Click here to add this to my saved trials
Evaluate Safety and Efficacy of the OPTIMIZER® System in Subjects With Moderate-to-Severe Heart Failure: FIX-HF-5C
Evaluation of the Safety and Efficacy of the OPTIMIZER® System in Subjects With Moderate-to-Severe Heart Failure With Ejection Fraction Between 25% and 45%: FIX-HF-5C
Status: Enrolling
Updated:  12/31/1969
mi
from
Spartanburg, SC
Evaluate Safety and Efficacy of the OPTIMIZER® System in Subjects With Moderate-to-Severe Heart Failure: FIX-HF-5C
Evaluation of the Safety and Efficacy of the OPTIMIZER® System in Subjects With Moderate-to-Severe Heart Failure With Ejection Fraction Between 25% and 45%: FIX-HF-5C
Status: Enrolling
Updated: 12/31/1969
Spartanburg Regional Medical Center
mi
from
Spartanburg, SC
Click here to add this to my saved trials
Evaluate Safety and Efficacy of the OPTIMIZER® System in Subjects With Moderate-to-Severe Heart Failure: FIX-HF-5C
Evaluation of the Safety and Efficacy of the OPTIMIZER® System in Subjects With Moderate-to-Severe Heart Failure With Ejection Fraction Between 25% and 45%: FIX-HF-5C
Status: Enrolling
Updated:  12/31/1969
mi
from
Germantown, TN
Evaluate Safety and Efficacy of the OPTIMIZER® System in Subjects With Moderate-to-Severe Heart Failure: FIX-HF-5C
Evaluation of the Safety and Efficacy of the OPTIMIZER® System in Subjects With Moderate-to-Severe Heart Failure With Ejection Fraction Between 25% and 45%: FIX-HF-5C
Status: Enrolling
Updated: 12/31/1969
Stern Cardiovascular Foundation
mi
from
Germantown, TN
Click here to add this to my saved trials
Evaluate Safety and Efficacy of the OPTIMIZER® System in Subjects With Moderate-to-Severe Heart Failure: FIX-HF-5C
Evaluation of the Safety and Efficacy of the OPTIMIZER® System in Subjects With Moderate-to-Severe Heart Failure With Ejection Fraction Between 25% and 45%: FIX-HF-5C
Status: Enrolling
Updated:  12/31/1969
mi
from
Dallas, TX
Evaluate Safety and Efficacy of the OPTIMIZER® System in Subjects With Moderate-to-Severe Heart Failure: FIX-HF-5C
Evaluation of the Safety and Efficacy of the OPTIMIZER® System in Subjects With Moderate-to-Severe Heart Failure With Ejection Fraction Between 25% and 45%: FIX-HF-5C
Status: Enrolling
Updated: 12/31/1969
Dallas VA Medical Center
mi
from
Dallas, TX
Click here to add this to my saved trials
Evaluate Safety and Efficacy of the OPTIMIZER® System in Subjects With Moderate-to-Severe Heart Failure: FIX-HF-5C
Evaluation of the Safety and Efficacy of the OPTIMIZER® System in Subjects With Moderate-to-Severe Heart Failure With Ejection Fraction Between 25% and 45%: FIX-HF-5C
Status: Enrolling
Updated:  12/31/1969
mi
from
Tyler, TX
Evaluate Safety and Efficacy of the OPTIMIZER® System in Subjects With Moderate-to-Severe Heart Failure: FIX-HF-5C
Evaluation of the Safety and Efficacy of the OPTIMIZER® System in Subjects With Moderate-to-Severe Heart Failure With Ejection Fraction Between 25% and 45%: FIX-HF-5C
Status: Enrolling
Updated: 12/31/1969
Trinity Clinic
mi
from
Tyler, TX
Click here to add this to my saved trials
Evaluate Safety and Efficacy of the OPTIMIZER® System in Subjects With Moderate-to-Severe Heart Failure: FIX-HF-5C
Evaluation of the Safety and Efficacy of the OPTIMIZER® System in Subjects With Moderate-to-Severe Heart Failure With Ejection Fraction Between 25% and 45%: FIX-HF-5C
Status: Enrolling
Updated:  12/31/1969
mi
from
Falls Church, VA
Evaluate Safety and Efficacy of the OPTIMIZER® System in Subjects With Moderate-to-Severe Heart Failure: FIX-HF-5C
Evaluation of the Safety and Efficacy of the OPTIMIZER® System in Subjects With Moderate-to-Severe Heart Failure With Ejection Fraction Between 25% and 45%: FIX-HF-5C
Status: Enrolling
Updated: 12/31/1969
Inova Heart and Vascular Institute
mi
from
Falls Church, VA
Click here to add this to my saved trials
Evaluate Safety and Efficacy of the OPTIMIZER® System in Subjects With Moderate-to-Severe Heart Failure: FIX-HF-5C
Evaluation of the Safety and Efficacy of the OPTIMIZER® System in Subjects With Moderate-to-Severe Heart Failure With Ejection Fraction Between 25% and 45%: FIX-HF-5C
Status: Enrolling
Updated:  12/31/1969
mi
from
Milwaukee, WI
Evaluate Safety and Efficacy of the OPTIMIZER® System in Subjects With Moderate-to-Severe Heart Failure: FIX-HF-5C
Evaluation of the Safety and Efficacy of the OPTIMIZER® System in Subjects With Moderate-to-Severe Heart Failure With Ejection Fraction Between 25% and 45%: FIX-HF-5C
Status: Enrolling
Updated: 12/31/1969
Aurora Health Care
mi
from
Milwaukee, WI
Click here to add this to my saved trials
Evaluate Safety and Efficacy of the OPTIMIZER® System in Subjects With Moderate-to-Severe Heart Failure: FIX-HF-5C
Evaluation of the Safety and Efficacy of the OPTIMIZER® System in Subjects With Moderate-to-Severe Heart Failure With Ejection Fraction Between 25% and 45%: FIX-HF-5C
Status: Enrolling
Updated:  12/31/1969
mi
from
Prague,
Evaluate Safety and Efficacy of the OPTIMIZER® System in Subjects With Moderate-to-Severe Heart Failure: FIX-HF-5C
Evaluation of the Safety and Efficacy of the OPTIMIZER® System in Subjects With Moderate-to-Severe Heart Failure With Ejection Fraction Between 25% and 45%: FIX-HF-5C
Status: Enrolling
Updated: 12/31/1969
Na Homolce Hospital
mi
from
Prague,
Click here to add this to my saved trials
Evaluate Safety and Efficacy of the OPTIMIZER® System in Subjects With Moderate-to-Severe Heart Failure: FIX-HF-5C
Evaluation of the Safety and Efficacy of the OPTIMIZER® System in Subjects With Moderate-to-Severe Heart Failure With Ejection Fraction Between 25% and 45%: FIX-HF-5C
Status: Enrolling
Updated:  12/31/1969
mi
from
Sayre, PA
Evaluate Safety and Efficacy of the OPTIMIZER® System in Subjects With Moderate-to-Severe Heart Failure: FIX-HF-5C
Evaluation of the Safety and Efficacy of the OPTIMIZER® System in Subjects With Moderate-to-Severe Heart Failure With Ejection Fraction Between 25% and 45%: FIX-HF-5C
Status: Enrolling
Updated: 12/31/1969
Guthrie Medical Group, PC
mi
from
Sayre, PA
Click here to add this to my saved trials
Evaluate Safety and Efficacy of the OPTIMIZER® System in Subjects With Moderate-to-Severe Heart Failure: FIX-HF-5C
Evaluation of the Safety and Efficacy of the OPTIMIZER® System in Subjects With Moderate-to-Severe Heart Failure With Ejection Fraction Between 25% and 45%: FIX-HF-5C
Status: Enrolling
Updated:  12/31/1969
mi
from
Glendale, AZ
Evaluate Safety and Efficacy of the OPTIMIZER® System in Subjects With Moderate-to-Severe Heart Failure: FIX-HF-5C
Evaluation of the Safety and Efficacy of the OPTIMIZER® System in Subjects With Moderate-to-Severe Heart Failure With Ejection Fraction Between 25% and 45%: FIX-HF-5C
Status: Enrolling
Updated: 12/31/1969
Cardiovascular Consultants, LTD
mi
from
Glendale, AZ
Click here to add this to my saved trials
Evaluate Safety and Efficacy of the OPTIMIZER® System in Subjects With Moderate-to-Severe Heart Failure: FIX-HF-5C
Evaluation of the Safety and Efficacy of the OPTIMIZER® System in Subjects With Moderate-to-Severe Heart Failure With Ejection Fraction Between 25% and 45%: FIX-HF-5C
Status: Enrolling
Updated:  12/31/1969
mi
from
Mesa, AZ
Evaluate Safety and Efficacy of the OPTIMIZER® System in Subjects With Moderate-to-Severe Heart Failure: FIX-HF-5C
Evaluation of the Safety and Efficacy of the OPTIMIZER® System in Subjects With Moderate-to-Severe Heart Failure With Ejection Fraction Between 25% and 45%: FIX-HF-5C
Status: Enrolling
Updated: 12/31/1969
Chan Heart Rhythm Institute
mi
from
Mesa, AZ
Click here to add this to my saved trials
Evaluate Safety and Efficacy of the OPTIMIZER® System in Subjects With Moderate-to-Severe Heart Failure: FIX-HF-5C
Evaluation of the Safety and Efficacy of the OPTIMIZER® System in Subjects With Moderate-to-Severe Heart Failure With Ejection Fraction Between 25% and 45%: FIX-HF-5C
Status: Enrolling
Updated:  12/31/1969
mi
from
Newport Beach, CA
Evaluate Safety and Efficacy of the OPTIMIZER® System in Subjects With Moderate-to-Severe Heart Failure: FIX-HF-5C
Evaluation of the Safety and Efficacy of the OPTIMIZER® System in Subjects With Moderate-to-Severe Heart Failure With Ejection Fraction Between 25% and 45%: FIX-HF-5C
Status: Enrolling
Updated: 12/31/1969
Hoag Memorial Hospital Presbyterian
mi
from
Newport Beach, CA
Click here to add this to my saved trials
Evaluate Safety and Efficacy of the OPTIMIZER® System in Subjects With Moderate-to-Severe Heart Failure: FIX-HF-5C
Evaluation of the Safety and Efficacy of the OPTIMIZER® System in Subjects With Moderate-to-Severe Heart Failure With Ejection Fraction Between 25% and 45%: FIX-HF-5C
Status: Enrolling
Updated:  12/31/1969
mi
from
Lincoln, NE
Evaluate Safety and Efficacy of the OPTIMIZER® System in Subjects With Moderate-to-Severe Heart Failure: FIX-HF-5C
Evaluation of the Safety and Efficacy of the OPTIMIZER® System in Subjects With Moderate-to-Severe Heart Failure With Ejection Fraction Between 25% and 45%: FIX-HF-5C
Status: Enrolling
Updated: 12/31/1969
Bryan Heart LGH
mi
from
Lincoln, NE
Click here to add this to my saved trials
Evaluate Safety and Efficacy of the OPTIMIZER® System in Subjects With Moderate-to-Severe Heart Failure: FIX-HF-5C
Evaluation of the Safety and Efficacy of the OPTIMIZER® System in Subjects With Moderate-to-Severe Heart Failure With Ejection Fraction Between 25% and 45%: FIX-HF-5C
Status: Enrolling
Updated:  12/31/1969
mi
from
Tucson, AZ
Evaluate Safety and Efficacy of the OPTIMIZER® System in Subjects With Moderate-to-Severe Heart Failure: FIX-HF-5C
Evaluation of the Safety and Efficacy of the OPTIMIZER® System in Subjects With Moderate-to-Severe Heart Failure With Ejection Fraction Between 25% and 45%: FIX-HF-5C
Status: Enrolling
Updated: 12/31/1969
Pima Heart
mi
from
Tucson, AZ
Click here to add this to my saved trials
Stress Echocardiography and Heart Computed Tomography (CT) Scan in Emergency Department Patients With Chest Pain
A Randomized Trial Comparing Coronary CT Angiography and Stress Echocardiography for Evaluation of Low-to-Intermediate Risk Emergency Department Chest Pain Patients
Status: Enrolling
Updated:  12/31/1969
mi
from
Bronx, NY
Stress Echocardiography and Heart Computed Tomography (CT) Scan in Emergency Department Patients With Chest Pain
A Randomized Trial Comparing Coronary CT Angiography and Stress Echocardiography for Evaluation of Low-to-Intermediate Risk Emergency Department Chest Pain Patients
Status: Enrolling
Updated: 12/31/1969
Montefiore Medical Center - Weiler / Einstein Division
mi
from
Bronx, NY
Click here to add this to my saved trials
Correlation of Somatic Dysfunction With Gastrointestinal Endoscopic Findings
Correlation of Somatic Dysfunction With Gastrointestinal Endoscopic Findings
Status: Enrolling
Updated:  12/31/1969
mi
from
Kirksville, MO
Correlation of Somatic Dysfunction With Gastrointestinal Endoscopic Findings
Correlation of Somatic Dysfunction With Gastrointestinal Endoscopic Findings
Status: Enrolling
Updated: 12/31/1969
Kirksville College of Osteopathic Medicine Family Practice Clinic
mi
from
Kirksville, MO
Click here to add this to my saved trials
ACAM2000® Myopericarditis Registry
ACAM2000® Myopericarditis Registry
Status: Enrolling
Updated:  12/31/1969
mi
from
San Diego, CA
ACAM2000® Myopericarditis Registry
ACAM2000® Myopericarditis Registry
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
San Diego, CA
Click here to add this to my saved trials
North American Study of Epistaxis in Hereditary Hemorrhagic Telangiectasia (HHT)
North American Study of Epistaxis in HHT (NOSE)
Status: Enrolling
Updated:  12/31/1969
mi
from
Los Angeles, CA
North American Study of Epistaxis in Hereditary Hemorrhagic Telangiectasia (HHT)
North American Study of Epistaxis in HHT (NOSE)
Status: Enrolling
Updated: 12/31/1969
University of California at Los Angeles
mi
from
Los Angeles, CA
Click here to add this to my saved trials
North American Study of Epistaxis in Hereditary Hemorrhagic Telangiectasia (HHT)
North American Study of Epistaxis in HHT (NOSE)
Status: Enrolling
Updated:  12/31/1969
mi
from
Augusta, GA
North American Study of Epistaxis in Hereditary Hemorrhagic Telangiectasia (HHT)
North American Study of Epistaxis in HHT (NOSE)
Status: Enrolling
Updated: 12/31/1969
Augusta University
mi
from
Augusta, GA
Click here to add this to my saved trials
North American Study of Epistaxis in Hereditary Hemorrhagic Telangiectasia (HHT)
North American Study of Epistaxis in HHT (NOSE)
Status: Enrolling
Updated:  12/31/1969
mi
from
Baltimore, MD
North American Study of Epistaxis in Hereditary Hemorrhagic Telangiectasia (HHT)
North American Study of Epistaxis in HHT (NOSE)
Status: Enrolling
Updated: 12/31/1969
Johns Hopkins University
mi
from
Baltimore, MD
Click here to add this to my saved trials
North American Study of Epistaxis in Hereditary Hemorrhagic Telangiectasia (HHT)
North American Study of Epistaxis in HHT (NOSE)
Status: Enrolling
Updated:  12/31/1969
mi
from
Salt Lake City, UT
North American Study of Epistaxis in Hereditary Hemorrhagic Telangiectasia (HHT)
North American Study of Epistaxis in HHT (NOSE)
Status: Enrolling
Updated: 12/31/1969
University of Utah
mi
from
Salt Lake City, UT
Click here to add this to my saved trials
North American Study of Epistaxis in Hereditary Hemorrhagic Telangiectasia (HHT)
North American Study of Epistaxis in HHT (NOSE)
Status: Enrolling
Updated:  12/31/1969
mi
from
Saint Louis, MO
North American Study of Epistaxis in Hereditary Hemorrhagic Telangiectasia (HHT)
North American Study of Epistaxis in HHT (NOSE)
Status: Enrolling
Updated: 12/31/1969
Washington University School of Medicine
mi
from
Saint Louis, MO
Click here to add this to my saved trials
North American Study of Epistaxis in Hereditary Hemorrhagic Telangiectasia (HHT)
North American Study of Epistaxis in HHT (NOSE)
Status: Enrolling
Updated:  12/31/1969
mi
from
Portland, OR
North American Study of Epistaxis in Hereditary Hemorrhagic Telangiectasia (HHT)
North American Study of Epistaxis in HHT (NOSE)
Status: Enrolling
Updated: 12/31/1969
Oregon Health and Sciences University
mi
from
Portland, OR
Click here to add this to my saved trials
Office-sclerotherapy for Epistaxis Due to Hereditary Hemorrhagic Telangiectasia
Office-sclerotherapy for Epistaxis Due to Hereditary Hemorrhagic Telangiectasia
Status: Enrolling
Updated:  12/31/1969
mi
from
Minneapolis, MN
Office-sclerotherapy for Epistaxis Due to Hereditary Hemorrhagic Telangiectasia
Office-sclerotherapy for Epistaxis Due to Hereditary Hemorrhagic Telangiectasia
Status: Enrolling
Updated: 12/31/1969
University of Minnesota Otolaryngology Clinic
mi
from
Minneapolis, MN
Click here to add this to my saved trials
Inappropriate Shock Reduction wIth PARAD+ Rhythm DiScrimination
Inappropriate Shock Reduction wIth PARAD+ Rhythm DiScrimination
Status: Enrolling
Updated:  12/31/1969
mi
from
Peoria, AZ
Inappropriate Shock Reduction wIth PARAD+ Rhythm DiScrimination
Inappropriate Shock Reduction wIth PARAD+ Rhythm DiScrimination
Status: Enrolling
Updated: 12/31/1969
Banner Arizona Medical Clinic
mi
from
Peoria, AZ
Click here to add this to my saved trials
Inappropriate Shock Reduction wIth PARAD+ Rhythm DiScrimination
Inappropriate Shock Reduction wIth PARAD+ Rhythm DiScrimination
Status: Enrolling
Updated:  12/31/1969
mi
from
Phoenix, AZ
Inappropriate Shock Reduction wIth PARAD+ Rhythm DiScrimination
Inappropriate Shock Reduction wIth PARAD+ Rhythm DiScrimination
Status: Enrolling
Updated: 12/31/1969
Banner Good Samaritan Medical Center
mi
from
Phoenix, AZ
Click here to add this to my saved trials
Inappropriate Shock Reduction wIth PARAD+ Rhythm DiScrimination
Inappropriate Shock Reduction wIth PARAD+ Rhythm DiScrimination
Status: Enrolling
Updated:  12/31/1969
mi
from
Toledo, OH
Inappropriate Shock Reduction wIth PARAD+ Rhythm DiScrimination
Inappropriate Shock Reduction wIth PARAD+ Rhythm DiScrimination
Status: Enrolling
Updated: 12/31/1969
Toledo Hospital
mi
from
Toledo, OH
Click here to add this to my saved trials
Inappropriate Shock Reduction wIth PARAD+ Rhythm DiScrimination
Inappropriate Shock Reduction wIth PARAD+ Rhythm DiScrimination
Status: Enrolling
Updated:  12/31/1969
mi
from
Easton, PA
Inappropriate Shock Reduction wIth PARAD+ Rhythm DiScrimination
Inappropriate Shock Reduction wIth PARAD+ Rhythm DiScrimination
Status: Enrolling
Updated: 12/31/1969
Easton Hospital
mi
from
Easton, PA
Click here to add this to my saved trials
Inappropriate Shock Reduction wIth PARAD+ Rhythm DiScrimination
Inappropriate Shock Reduction wIth PARAD+ Rhythm DiScrimination
Status: Enrolling
Updated:  12/31/1969
mi
from
Columbia, SC
Inappropriate Shock Reduction wIth PARAD+ Rhythm DiScrimination
Inappropriate Shock Reduction wIth PARAD+ Rhythm DiScrimination
Status: Enrolling
Updated: 12/31/1969
Providence Hospital
mi
from
Columbia, SC
Click here to add this to my saved trials
Inappropriate Shock Reduction wIth PARAD+ Rhythm DiScrimination
Inappropriate Shock Reduction wIth PARAD+ Rhythm DiScrimination
Status: Enrolling
Updated:  12/31/1969
mi
from
Mount Pleasant, SC
Inappropriate Shock Reduction wIth PARAD+ Rhythm DiScrimination
Inappropriate Shock Reduction wIth PARAD+ Rhythm DiScrimination
Status: Enrolling
Updated: 12/31/1969
Carolina Arrhythmia Consultants
mi
from
Mount Pleasant, SC
Click here to add this to my saved trials
Inappropriate Shock Reduction wIth PARAD+ Rhythm DiScrimination
Inappropriate Shock Reduction wIth PARAD+ Rhythm DiScrimination
Status: Enrolling
Updated:  12/31/1969
mi
from
Mesa, AZ
Inappropriate Shock Reduction wIth PARAD+ Rhythm DiScrimination
Inappropriate Shock Reduction wIth PARAD+ Rhythm DiScrimination
Status: Enrolling
Updated: 12/31/1969
Southwest Cardiovascular Associates
mi
from
Mesa, AZ
Click here to add this to my saved trials
Inappropriate Shock Reduction wIth PARAD+ Rhythm DiScrimination
Inappropriate Shock Reduction wIth PARAD+ Rhythm DiScrimination
Status: Enrolling
Updated:  12/31/1969
mi
from
Mesa, AZ
Inappropriate Shock Reduction wIth PARAD+ Rhythm DiScrimination
Inappropriate Shock Reduction wIth PARAD+ Rhythm DiScrimination
Status: Enrolling
Updated: 12/31/1969
Pacific Arrhythmia Services
mi
from
Mesa, AZ
Click here to add this to my saved trials
Inappropriate Shock Reduction wIth PARAD+ Rhythm DiScrimination
Inappropriate Shock Reduction wIth PARAD+ Rhythm DiScrimination
Status: Enrolling
Updated:  12/31/1969
mi
from
Anaheim, CA
Inappropriate Shock Reduction wIth PARAD+ Rhythm DiScrimination
Inappropriate Shock Reduction wIth PARAD+ Rhythm DiScrimination
Status: Enrolling
Updated: 12/31/1969
Southern California Electrophysiology Associates
mi
from
Anaheim, CA
Click here to add this to my saved trials
Inappropriate Shock Reduction wIth PARAD+ Rhythm DiScrimination
Inappropriate Shock Reduction wIth PARAD+ Rhythm DiScrimination
Status: Enrolling
Updated:  12/31/1969
mi
from
Burbank, CA
Inappropriate Shock Reduction wIth PARAD+ Rhythm DiScrimination
Inappropriate Shock Reduction wIth PARAD+ Rhythm DiScrimination
Status: Enrolling
Updated: 12/31/1969
Raymond H. M. Schaerf MD, Inc.
mi
from
Burbank, CA
Click here to add this to my saved trials